MPI Research helps drug developers answer a crucial question: Is it safe? The contract research organization (CRO) specializes in providing preclinical and early clinical research services to pharmaceutical, medical device, chemical, biotechnology, and agricultural development companies, as well as regulatory and other government agencies. Its toxicology testing services investigate and determine the safety and dosage levels of substances being considered for use in drugs, pesticides, petrochemicals, and food additives. MPI Research, which serves clients in more than 30 countries, also offers contract bioanalytical, pharmacology, discovery diagnostic, and animal testing services.
The company looks to expand by forming new contracts to conduct research for new clients. It primarily targets drug manufacturers in industries such as cardiology, endocrinology, renal and metabolic disease, infections, ophthalmics, and oncology.
Although MPI Research undertook some restructuring and cost-cutting initiatives amid a period of slow growth (because of increased competition and cuts in potential clients' R&D budgets), the company reports that "significant" growth over the past year has led it to expand its capacity and purchase a second Gyros Gyrolab, which helps manage the assay workflow. MPI Research is the first CRO in North America to own two of the workstations. – less
13 salaries reported
$31,263 per year
10 salaries reported
$13.49 per hour
3 salaries reported
$19.83 per hour